Evidence map›Paper›PMID 23770926›Full record

ArticleRNA biology2013

miR-122 and the Hepatitis C RNA genome: more than just stability.

You Li, Takahiro Masaki, Stanley M Lemon

Open access · bronzeAbstract read
In one paragraph

Article in RNA biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. The functional role of exosome in hepatocellular carcinoma.Journal of cancer research and clinical oncology · 2018
    Review
  6. Review
  7. Profiles of miRNAs in serum in severe acute drug induced liver injury and their prognostic significance.Liver international : official journal of the International Association for the Study of the Liver · 2017
    Article
  8. miR-122 inhibits cancer cell malignancy by targeting PKM2 in gallbladder carcinoma.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
    Article
  9. Pigmy MicroRNA: surveillance cops in Therapies kingdom.Molecular medicine (Cambridge, Mass.) · 2016
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

You LiDepartment of Medicine, and Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Takahiro Masaki
Stanley M Lemon
University of North Carolina at Chapel Hill · US

Funding

Micro-RNA 122 and Chronic Hepatitis CR01AI095690 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LEMON, STANLEY M. · 2011 to 2020
$3.7M
Murine Model of HCV-Associated Human Liver CancerR01CA164029 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LEMON, STANLEY M., SU, LISHAN · 2012 to 2016
$2.3M
NCI NIH HHS R01 CA164029NCI NIH HHS R01-CA164029NIAID NIH HHS R01 AI095690NIAID NIH HHS R01-AI095690
6 · The paper itself

Abstract

MicroRNA-122 (miR-122) plays a key role in hepatitis C virus (HCV) replication, but understanding exactly how it functions in the viral lifecycle has been elusive. HCV is a positive-strand virus with a messenger-sense RNA genome, to which miR-122 binds in a non-canonical fashion at two sites near the 5' end. Recent studies show that miR-122 recruits Ago-2 to the genomic RNA, stabilizing it and slowing its decay in infected cells. This led us to investigate decay pathways that mediate degradation of the viral RNA. We found HCV RNA is degraded primarily by the cytoplasmic 5' exonuclease Xrn1 in infected cells. miR-122 lost its stabilizing effect when cells were depleted of Xrn1 using an RNAi strategy, providing strong evidence that miR-122 acts to protect the viral RNA from Xrn1-mediated 5' exonucleolytic decay. However, Xrn1 depletion did not rescue replication of a viral mutant defective in miR-122 binding, indicating that there is much more to miR-122's actions than prevention of Xrn1 decay. Here, we consider the role of miR-122 in the viral lifecycle, and explore the possibility that it might function directly in viral RNA synthesis.

Indexed as

5' Untranslated RegionsCell Line, TumorExonucleasesHepacivirusHumansMicroRNAsRNA InterferenceRNA, MessengerRNA StabilityRNA, ViralVirus Replication5' Untranslated RegionsExonucleasesMicroRNAsMIRN122 microRNA, humanRNA, MessengerRNA, Viralhepatitis C virusmicro-RNAPCBP2replicationRNA decayRNA stabilitytranslationXrn1

Identifiers

PMID23770926
PMCPMC3904590
OpenAlexW1516178645

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.